OSE Pharma SA Net Asset Quality Index
OSE Pharma SA net asset quality index. OSE Pharma SA (OSE) has a Net Asset Quality Index of 48.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €104.18 Million minus total liabilities of €53.58 Million yields net assets of €50.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. See OSE net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of OSE Pharma SA (2012–2024)
Net asset quality index of OSE Pharma SA from 2012 to 2024. This chart shows how OSE Pharma SA's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the index stands at 48.6%, representing net assets of €50.60 Million against total assets of €104.18 Million EUR. Check OSE strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
OSE Pharma SA Net Asset Quality Index by Year (2012–2024)
OSE Pharma SA net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for OSE Pharma SA from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of OSE Pharma SA.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 51.5% | €63.81 Million | €123.96 Million | €60.15 Million | ▲ +23.5 pp |
| 2023 | 28.0% | €22.98 Million | €82.05 Million | €59.08 Million | ▼ -7.5 pp |
| 2022 | 35.5% | €32.55 Million | €91.67 Million | €59.12 Million | ▼ -11.3 pp |
| 2021 | 46.8% | €47.53 Million | €101.52 Million | €53.99 Million | ▼ -16.4 pp |
| 2020 | 63.2% | €61.24 Million | €96.85 Million | €35.61 Million | ▼ -2.6 pp |
| 2019 | 65.8% | €58.49 Million | €88.89 Million | €30.40 Million | ▼ -14.5 pp |
| 2018 | 80.3% | €61.75 Million | €76.90 Million | €15.15 Million | ▲ +8.6 pp |
| 2017 | 71.7% | €55.45 Million | €77.35 Million | €21.91 Million | ▼ -0.4 pp |
| 2016 | 72.1% | €64.53 Million | €89.55 Million | €25.02 Million | ▼ -13.1 pp |
| 2015 | 85.2% | €14.48 Million | €17.00 Million | €2.52 Million | ▲ +125.7 pp |
| 2014 | -40.6% | €-803.00K | €1.98 Million | €2.78 Million | ▲ +216.6 pp |
| 2013 | -257.1% | €-864.00K | €336.00K | €1.20 Million | ▼ -32.7 pp |
| 2012 | -224.5% | €-633.00K | €282.00K | €915.00K | — |